Skip to main content
Explore URMC
menu

SILDI-SAFE: Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia

Research Question:
What is the safety and preliminary effectiveness of sildenafil in premature infants with severe Bronchopulmonary Dysplasia (BPD)?

Basic Study Information

Purpose:
This is a multicenter study of sildenafil in premature infants in Neonatal Intensive Care Units (NICUs) with severe bronchopulmonary dysplasia (BPD). Infants must be receiving respiratory support at enrollment.

Location: University of Rochester School of Medicine Children's Hospital
Study Reference #: STUDY00006543

Lead Researcher (Principal Investigator)

Lead Researcher:  Gloria Pryhuber

Study Contact Information

Study Coordinator: Elizabeth Carbonell, MPH, CCRC
Phone: (585) 273-2322
Email: elizabeth_carbonell@urmc.rochester.edu

Additional Study Details

Return to Search